State Street
ORTX

State Street’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

State Street’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,037
Closed -$64K – 4967
2022
Q2 		$64K Sell
11,037
-98
-0.9% -$553 ﹤0.01% 4671
2022
Q1 		$79K Buy
11,135
+491
+5% +$4.81K ﹤0.01% 4705
2021
Q4 		$141K Sell
10,644
-5,651
-35% -$93.5K ﹤0.01% 4484
2021
Q3 		$375K Buy
16,295
+6,012
+58% +$179K ﹤0.01% 4092
2021
Q2 		$451K Sell
10,283
-10,791
-51% -$601K ﹤0.01% 3897
2021
Q1 		$1.53M Buy
21,074
+1,242
+6% +$88.2K ﹤0.01% 3530
2020
Q4 		$857K Buy
19,832
+2,677
+16% +$120K ﹤0.01% 3584
2020
Q3 		$705K Sell
17,155
-3,006
-15% -$155K ﹤0.01% 3517
2020
Q2 		$1.21M Buy
20,161
+12,571
+166% +$1.15M ﹤0.01% 3364
2020
Q1 		$572K Buy
7,590
+3,525
+87% +$406K ﹤0.01% 3421
2019
Q4 		$559K Buy
4,065
+815
+25% +$99.1K ﹤0.01% 3505
2019
Q3 		$386K Buy
+3,250
New +$454K ﹤0.01% 3537

Other funds holding ORTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street's ORTX Position: Q3 2022 in Review

State Street sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q3 2022, closing a stake of 11,037 shares — an estimated $64K sold.

State Street first reported a position in ORTX in Q3 2019 and held it in 12 quarters. The position peaked at $1.53M in Q1 2021. 47 funds tracked by Wall St. Rank hold ORTX as of Q3 2022.

  • State Street reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • State Street sold 11,037 Orchard Therapeutics plc American Depositary Shares shares in Q3 2022, an estimated $64K.
  • State Street first reported a position in Orchard Therapeutics plc American Depositary Shares in Q3 2019 and held it in 12 quarters.
  • State Street's Orchard Therapeutics plc American Depositary Shares position peaked at $1.53M in Q1 2021.
  • 47 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2022.

Based on State Street's 13F filing for Q3 2022, filed 15 Nov 2022.